Charlotte's Web Holdings (CWBHF) Share-based Compensation (2021 - 2026)
Charlotte's Web Holdings' (CWBHF) quarterly Share-based Compensation came in at $151000.0 in Q1 2026, down 19.25% year-on-year from $187000.0 in Q1 2025, and down 0.66% on a QoQ basis from $152000.0 in Q4 2025.
Charlotte's Web Holdings (CWBHF) Share-based Compensation (2021 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has 6 years of Share-based Compensation data on file, last reported at $151000.0 in Q1 2026.
- On a quarterly basis, Share-based Compensation fell 19.25% year-over-year to $151000.0 in Q1 2026; TTM through Mar 2026 was $628000.0, a 27.4% decrease from a year earlier, with the FY2025 full-year figure at $664000.0, down 56.32% from the prior year.
- Share-based Compensation for Q1 2026 stood at $151000.0, down from $152000.0 in the prior quarter.
- Over the last five years, Share-based Compensation for CWBHF reached as high as $1.4 million in Q1 2022 and fell as low as $145000.0 in Q3 2025.
- Historically, Share-based Compensation has averaged $440882.4 across 5 years, with a median of $374000.0 in 2022.
- Across the five-year window, Share-based Compensation soared 124.53% in 2024 and sank 77.79% in 2025, its largest moves.
- Year by year, Share-based Compensation stood at $374000.0 in 2022, then gained by 21.39% to $454000.0 in 2023, then sank by 50.66% to $224000.0 in 2024, then plunged by 32.14% to $152000.0 in 2025, then decreased by 0.66% to $151000.0 in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $151000.0 in Q1 2026, $152000.0 in Q4 2025, and $145000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 43.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 25.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 125.69 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 58.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 56.50 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 55.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.00 Mn |
| 10 | Charlotte's Web Holdings | 41.51 Mn | 36.32 Mn | 5.20 Mn | 151,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 151,000.00 |
| Mar 31, 2026 | 151,000.00 |
| Dec 31, 2025 | 152,000.00 |
| Dec 31, 2025 | 152,000.00 |
| Sep 30, 2025 | 145,000.00 |
| Sep 30, 2025 | 145,000.00 |
| Jun 30, 2025 | 180,000.00 |
| Jun 30, 2025 | 180,000.00 |
| Mar 31, 2025 | 187,000.00 |
| Mar 31, 2025 | 187,000.00 |
| Dec 31, 2024 | 224,000.00 |
| Dec 31, 2024 | 224,000.00 |
| Sep 30, 2024 | 217,000.00 |
| Sep 30, 2024 | 217,000.00 |
| Jun 30, 2024 | 237,000.00 |
| Jun 30, 2024 | 237,000.00 |
| Mar 31, 2024 | 842,000.00 |
| Mar 31, 2024 | 842,000.00 |
| Dec 31, 2023 | 454,000.00 |
| Dec 31, 2023 | 454,000.00 |